Clinical Trial Update: A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring whether a freeze-dried fecal microbiota therapy can treat diarrhea-predominant irritable bowel syndrome or prevent recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• Freeze-dried fecal microbiota therapy (fecal microbiota transplantation (FMT) - freeze-dried formulation)

Snippet

Sponsor: PharmaPlanter Technologies Inc | Conditions: Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D), Recurrent Clostridioides Difficile Infection (rCDI) | Phase 2 | Status: NOT_YET_RECRUITING